|
|
Br J Cancer. 1987 April; 55(4): 437–442. | PMCID: PMC2001687 |
Angio-immunoblastic lymphadenopathy: a clinical, immunological and molecular study. T. S. Ganesan, H. S. Dhaliwal, M. S. Dorreen, A. G. Stansfeld, J. A. Habeshaw, and T. A. Lister Abstract Twenty four patients with angio-immunoblastic lymphadenopathy (AILD) presenting between 1974 and 1985 have been reviewed. Clinical features at presentation included rash, fever, lymphadenopathy and hepatosplenomegaly in 75% of patients. Polyclonal hypergammaglobulinaemia was seen in 19/20 patients; 5 had normal immunoglobulin levels. Combination chemotherapy with MVPP was the optimal treatment with 6/7 patients achieving complete remission. Duration of remission ranged from 9 months to 4 years and was significantly longer in patients achieving complete as opposed to partial remission. In 6 patients phenotype studies were performed on single cell suspensions and immunoperoxidase studies on frozen sections of 7 lymph nodes. There was a reversal of the normal T suppressor/helper cell ratio with a predominance of T suppressor cells. Loss of normal B follicles was observed histologically in all except one lymph node. Germline configuration of the beta B-chain of the T cell receptor was observed in lymph nodes of 4 patients with AILD, and a rearranged T cell receptor was observed in 1 patient in whom a second lymph node biopsy had shown alteration of the histological picture to that of T-zone lymphoma. Frozen sera of 15 patients were screened for antibodies to HTLV I and III and were found to be negative. Full text Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.1M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References. These references are in PubMed. This may not be the complete list of references from this article. - Bernengo MG, Levi L, Zina G. Skin lesions in angioimmunoblastic lymphadenopathy: histological and immunological studies. Br J Dermatol. 1981 Feb;104(2):131–139. [PubMed]
- Bertness V, Kirsch I, Hollis G, Johnson B, Bunn PA., Jr T-cell receptor gene rearrangements as clinical markers of human T-cell lymphomas. N Engl J Med. 1985 Aug 29;313(9):534–538. [PubMed]
- Blumenfeld W, Beckstead JH. Angioimmunoblastic lymphadenopathy with dysproteinemia in homosexual men with acquired immune deficiency syndrome. Arch Pathol Lab Med. 1983 Nov;107(11):567–569. [PubMed]
- Clark DM, Boylston AW, Hall PA, Carrel S. Antibodies to T cell antigen receptor beta chain families detect monoclonal T cell proliferation. Lancet. 1986 Oct 11;2(8511):835–837. [PubMed]
- Cullen MH, Stansfeld AG, Oliver RT, Lister TA, Malpas JS. Angio-immunoblastic lymphadenopathy: report of ten cases and review of the literature. Q J Med. 1979 Jan;48(189):151–177. [PubMed]
- Dorreen MS, Habeshaw JA, Stansfeld AG, Wrigley PF, Lister TA. Characteristics of Sternberg-Reed, and related cells in Hodgkin's disease: an immunohistological study. Br J Cancer. 1984 Apr;49(4):465–476. [PubMed]
- Dorreen MS, Habeshaw JA, Wrigley PF, Lister TA. Distribution of T-lymphocyte subsets in Hodgkin's disease characterized by monoclonal antibodies. Br J Cancer. 1982 Apr;45(4):491–499. [PubMed]
- Ford AM, Molgaard HV, Greaves MF, Gould HJ. Immunoglobulin gene organisation and expression in haemopoietic stem cell leukaemia. EMBO J. 1983;2(6):997–1001. [PubMed]
- Frizzera G, Moran EM, Rappaport H. Angio-immunoblastic lymphadenopathy with dysproteinaemia. Lancet. 1974 Jun 1;1(7866):1070–1073. [PubMed]
- Frizzera G, Moran EM, Rappaport H. Angio-immunoblastic lymphadenopathy. Diagnosis and clinical course. Am J Med. 1975 Dec;59(6):803–818. [PubMed]
- Lukes RJ, Tindle BH. Immunoblastic lymphadenopathy. A hyperimmune entity resembling Hodgkin's disease. N Engl J Med. 1975 Jan 2;292(1):1–8. [PubMed]
- Nathwani BN, Rappaport H, Moran EM, Pangalis GA, Kim H. Malignant lymphoma arising in angioimmunoblastic lymphadenopathy. Cancer. 1978 Feb;41(2):578–606. [PubMed]
- Neiman RS, Dervan P, Haudenschild C, Jaffe R. Angioimmunoblastic lymphadenopathy: an ultrastructural and immunologic study with review of the literature. Cancer. 1978 Feb;41(2):507–518. [PubMed]
- Newcom SR, Kadin ME. Prednisone in treatment of allergen-associated angio-immunoblastic lymphadenopathy. Lancet. 1979 Mar 3;1(8114):462–464. [PubMed]
- Anti-inflammatory drugs and tumour growth. Lancet. 1979 Feb 24;1(8113):420–421. [PubMed]
- O'Connor NT, Crick JA, Wainscoat JS, Gatter KC, Stein H, Falini B, Mason DY. Evidence for monoclonal T lymphocyte proliferation in angioimmunoblastic lymphadenopathy. J Clin Pathol. 1986 Nov;39(11):1229–1232. [PubMed]
- Pangalis GA, Moran EM, Nathwani BN, Zelman RJ, Kim H, Rappaport H. Angioimmunoblastic lymphadenopathy. Long-term follow-up study. Cancer. 1983 Jul 15;52(2):318–321. [PubMed]
- Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A. 1980 Dec;77(12):7415–7419. [PubMed]
- Sarngadharan MG, Popovic M, Bruch L, Schüpbach J, Gallo RC. Antibodies reactive with human T-lymphotropic retroviruses (HTLV-III) in the serum of patients with AIDS. Science. 1984 May 4;224(4648):506–508. [PubMed]
- Schauer PK, Straus DJ, Bagley CM, Jr, Rudolph RH, McCracken JD, Huff J, Glucksburg H, Bauermeister DE, Clarkson BD. Angioimmunoblastic lymphadenopathy: clinical spectrum of disease. Cancer. 1981 Dec 1;48(11):2493–2498. [PubMed]
- Southern EM. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol. 1975 Nov 5;98(3):503–517. [PubMed]
- Stensvold K, Brandtzaeg P, Kvaløy S, Seip M, Lie SO. Immunoblastic lymphadenopathy with early onset in two boys: immunohistochemical study and indication of decreased proportion of circulating T-helper cells. Br J Haematol. 1984 Mar;56(3):417–430. [PubMed]
- Sutcliffe SB, Wrigley PF, Peto J, Lister TA, Stansfeld AG, Whitehouse JM, Crowther D, Malpas JS. MVPP chemotherapy regimen for advanced Hodgkin's disease. Br Med J. 1978 Mar 18;1(6114):679–683. [PubMed]
- Watanabe H. Association of immunoblastic lymphadenopathy and Hashimoto's thyroiditis. Ann Intern Med. 1977 Jul;87(1):62–64. [PubMed]
- Watanabe S, Shimosato Y, Shimoyama M, Minato K, Suzuki M, Abe M, Nagatani T. Adult T cell lymphoma with hypergammaglobulinemia. Cancer. 1980 Dec 1;46(11):2472–2483. [PubMed]
- Weiss LM, Strickler JG, Dorfman RF, Horning SJ, Warnke RA, Sklar J. Clonal T-cell populations in angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy-like lymphoma. Am J Pathol. 1986 Mar;122(3):392–397. [PubMed]
- Yoshikai Y, Anatoniou D, Clark SP, Yanagi Y, Sangster R, Van den Elsen P, Terhorst C, Mak TW. Sequence and expression of transcripts of the human T-cell receptor beta-chain genes. Nature. 312(5994):521–524. [PubMed]
|